Results: 101-125/1697
Authors:
Vreeburg, EM
Levi, M
Rauws, EAJ
Deventer, SJHV
Snel, P
Bartelsman, JWFM
Ten Cate, JW
Tytgat, GNJ
Citation: Em. Vreeburg et al., Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhageand the beneficial effect of acid suppression, ALIM PHARM, 15(5), 2001, pp. 639-646
Authors:
Katz, PO
Xue, S
Castell, DO
Citation: Po. Katz et al., Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg, ALIM PHARM, 15(5), 2001, pp. 647-652
Authors:
Coulie, B
Camilleri, M
Bharucha, AE
Sandborn, WJ
Burton, D
Citation: B. Coulie et al., Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine an colonic motility in patients and healthy subjects, ALIM PHARM, 15(5), 2001, pp. 653-663
Authors:
McCormack, G
O'Donoghue, D
Baird, A
Citation: G. Mccormack et al., In-vitro cyclosporin sensitivity of proliferating lymphocytes is predictive of in-vivo therapeutic response in ulcerative colitis, ALIM PHARM, 15(5), 2001, pp. 665-668
Authors:
Metz, DC
Buchanan, M
Purich, E
Fein, S
Citation: Dc. Metz et al., A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison Syndrome, ALIM PHARM, 15(5), 2001, pp. 669-676
Authors:
Pohle, T
Brzozowski, T
Becker, JC
Van der Voort, IR
Markmann, A
Konturek, SJ
Moniczewski, A
Domschke, W
Konturek, JW
Citation: T. Pohle et al., Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C, ALIM PHARM, 15(5), 2001, pp. 677-687
Authors:
Papatheodoridis, GV
Papadimitropoulos, VC
Hadziyannis, SJ
Citation: Gv. Papatheodoridis et al., Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis., ALIM PHARM, 15(5), 2001, pp. 689-698
Authors:
Graham, DY
Reddy, S
Citation: Dy. Graham et S. Reddy, Rapid detection of anti-Helicobacter pylori IgG in urine using immunochromatography, ALIM PHARM, 15(5), 2001, pp. 699-702
Authors:
Szeto, ML
Lee, CK
Yee, YK
Li, KF
Lee, WK
Lee, CC
Que, TL
Wong, BCY
Citation: Ml. Szeto et al., Evaluation of five commercial serological tests for the detection of Helicobacter pylori infection in Chinese, ALIM PHARM, 15(5), 2001, pp. 703-706
Authors:
Tankovic, J
Lamarque, D
Lascols, C
Soussy, CJ
Delchier, JC
Citation: J. Tankovic et al., Impact of Helicobacter pylori resistance to clarithromycin on the efficacyof the omeprazole-amoxcillin-clarithromycin therapy, ALIM PHARM, 15(5), 2001, pp. 707-713
Authors:
Suzuki, H
Mori, M
Seto, K
Miyazawa, M
Kai, A
Suematsu, M
Yoneta, T
Miura, S
Ishii, H
Citation: H. Suzuki et al., Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils - a study using intravital videomicroscopy, ALIM PHARM, 15(5), 2001, pp. 715-725
Authors:
Beales, ILP
Citation: Ilp. Beales, H-pylori-gastrin link in malt lymphoma, ALIM PHARM, 15(5), 2001, pp. 727-728
Authors:
Konturek, SJ
Citation: Sj. Konturek, H-pylori-gastrin link in malt lymphoma - Reply, ALIM PHARM, 15(5), 2001, pp. 728-729
Authors:
Waldum, HL
Citation: Hl. Waldum, H-pylori-gastrin link in malt lymphoma, ALIM PHARM, 15(5), 2001, pp. 729-730
Authors:
Oldenburg, B
Koningsberger, JC
Henegouwen, GPV
Van Asbeck, BS
Marx, JJM
Citation: B. Oldenburg et al., Review article: iron and inflammatory bowel disease., ALIM PHARM, 15(4), 2001, pp. 429-438
Authors:
Zar, S
Kumar, D
Benson, MJ
Citation: S. Zar et al., Review article: food hypersensitivity and irritable bowel syndrome, ALIM PHARM, 15(4), 2001, pp. 439-449
Authors:
Souza, RF
Citation: Rf. Souza, Review article: a molecular rationale for the how, when and why of colorectal cancer screening, ALIM PHARM, 15(4), 2001, pp. 451-462
Authors:
Cornillie, F
Shealy, D
D'Haens, G
Geboes, K
Van Assche, G
Ceuppens, J
Wagner, C
Schaible, T
Plevy, SE
Targan, SR
Rutgeerts, P
Citation: F. Cornillie et al., Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease, ALIM PHARM, 15(4), 2001, pp. 463-473
Authors:
Blomqvist, P
Feltelius, N
Lofberg, R
Ekbom, A
Citation: P. Blomqvist et al., A 10-year survey of inflammatory bowel diseases - drug therapy, costs and adverse reactions, ALIM PHARM, 15(4), 2001, pp. 475-481
Authors:
Norgard, B
Czeizel, AE
Rockenbauer, M
Olsen, J
Sorensen, HT
Citation: B. Norgard et al., Population-based case control study of the safety of sulfasalazine use during pregnancy, ALIM PHARM, 15(4), 2001, pp. 483-486
Authors:
Osato, MS
Reddy, SG
Piergies, AA
Bochenek, WJ
Testa, RT
Graham, DY
Citation: Ms. Osato et al., Comparative efficacy of new investigational agents against Helicobacter pylori, ALIM PHARM, 15(4), 2001, pp. 487-492
Authors:
Wong, BCY
Wang, WH
Berg, DE
Fung, FMY
Wong, KW
Wong, WM
Lai, KC
Cho, CH
Hui, WM
Lam, SK
Citation: Bcy. Wong et al., High prevalence of mixed infections by Helicobacter pylori in Hong Kong: metronidazole sensitivity and overall genotype, ALIM PHARM, 15(4), 2001, pp. 493-503
Authors:
Wong, BCY
Wong, WM
Wang, WH
Tang, VSY
Young, J
Lai, KC
Yuen, ST
Leung, SY
Hu, WHC
Chan, CK
Hui, WM
Lam, SK
Citation: Bcy. Wong et al., An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese, ALIM PHARM, 15(4), 2001, pp. 505-511
Authors:
Graham, DY
Saeed, MA
Hoffman, J
El-Zimaity, HMT
Kwon, DH
Osato, MS
Citation: Dy. Graham et al., Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effectof metronidazole resistance, ALIM PHARM, 15(4), 2001, pp. 513-518
Authors:
Srinivasan, R
Katz, PO
Ramakrishnan, A
Katzka, DA
Vela, MF
Castell, DO
Citation: R. Srinivasan et al., Maximal acid reflux control for Barrett's oesophagus: feasible and effective, ALIM PHARM, 15(4), 2001, pp. 519-524